Oxidative alterations in Alzheimer's disease

被引:2
|
作者
Markesbery, WR [1 ]
Carney, JM
机构
[1] Univ Kentucky, Med Ctr, Dept Pathol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[2] Univ Kentucky, Med Ctr, Dept Pathol, Alzheimers Dis Res Ctr, Lexington, KY 40536 USA
[3] Univ Kentucky, Med Ctr, Dept Neurol, Alzheimers Dis Res Ctr, Lexington, KY 40536 USA
[4] Univ Kentucky, Med Ctr, Dept Neurol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[5] Centaur Pharmaceut Inc, Sunnyvale, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is increasing evidence that free radical damage to brain lipids, carbohydrates, proteins, and DNA is involved in neuron death in neurodegenerative disorders, The largest number of studies have been performed in Alzheimer's disease (AD) where there is considerable support for the oxidative stress hypothesis in the pathogenesis of neuron degeneration. In autopsied brain there is an increase in lipid peroxidation, a decline in polyunsaturated fatty acids (PUFA) and an increase in 4-hydroxynonenal (HNE), a neurotoxic aldehyde product of PUFA oxidation, Increased protein oxidation and a marked decline in oxidative-sensitive enzymes, glutamine synthetase and creatinine kinase, are found in the brain in AD, Increased DNA oxidation, especially 8-hydroxy-2'-deoxyguanosine (8-OHdG) is present in the brain in AD. Immunohistochemical studies show the presence of oxidative stress products in neurofibrillary tangles and senile plaques in AD. Markers of lipid peroxidation (HNE, isoprostanes) and DNA (8-OHdG) are increased in CSF in AD, In addition, inflammatory response markers (the complement cascade, cytokines, acute phase reactants and proteases) are present in the brain in AD, These findings, coupled with epidemiologic studies showing that anti-inflammatory agents slow the progression or delay the onset of AD, suggest that inflammation plays a role in AD. Overall these studies indicate that oxidative stress and the inflammatory cascade, working in concert, are important in the pathogenetic cascade of neurodegeneration in AD, suggesting that therapeutic efforts aimed at both of these mechanisms may be beneficial.
引用
收藏
页码:133 / 146
页数:14
相关论文
共 50 条
  • [21] Mitochondrial alterations in synapses in Alzheimer's disease
    Baloyannis, S. J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 283 (1-2) : 283 - 283
  • [22] Gut microbiome alterations in Alzheimer's disease
    Vogt, Nicholas M.
    Kerby, Robert L.
    Dill-McFarland, Kimberly A.
    Harding, Sandra J.
    Merluzzi, Andrew P.
    Johnson, Sterling C.
    Carlsson, Cynthia M.
    Asthana, Sanjay
    Zetterberg, Henrik
    Blennow, Kaj
    Bendlin, Barbara B.
    Rey, Federico E.
    SCIENTIFIC REPORTS, 2017, 7
  • [23] Alterations in Glucose Metabolism in Alzheimer's Disease
    Calsolaro, Valeria
    Edison, Paul
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2016, 10 (01) : 31 - 39
  • [24] Gut microbiome alterations in Alzheimer’s disease
    Nicholas M. Vogt
    Robert L. Kerby
    Kimberly A. Dill-McFarland
    Sandra J. Harding
    Andrew P. Merluzzi
    Sterling C. Johnson
    Cynthia M. Carlsson
    Sanjay Asthana
    Henrik Zetterberg
    Kaj Blennow
    Barbara B. Bendlin
    Federico E. Rey
    Scientific Reports, 7
  • [25] Alterations of Audiovisual Integration in Alzheimer's Disease
    Liu, Yufei
    Wang, Zhibin
    Wei, Tao
    Zhou, Shaojiong
    Yin, Yunsi
    Mi, Yingxin
    Liu, Xiaoduo
    Tang, Yi
    NEUROSCIENCE BULLETIN, 2023, 39 (12) : 1859 - 1872
  • [26] Alterations of Brain Capillaries in Alzheimer's Disease
    Baloyannis, Stavros J.
    Mavroudis, Ioannis
    Baloyannis, Ioannis S.
    Psaroulis, Demetrios
    ANNALS OF NEUROLOGY, 2013, 74 : S15 - S16
  • [27] Alterations of Audiovisual Integration in Alzheimer’s Disease
    Yufei Liu
    Zhibin Wang
    Tao Wei
    Shaojiong Zhou
    Yunsi Yin
    Yingxin Mi
    Xiaoduo Liu
    Yi Tang
    Neuroscience Bulletin, 2023, 39 : 1859 - 1872
  • [28] Dopaminergic Alterations in Patients with Alzheimer's Disease
    Azharuddin, M.
    Sharma, M.
    MOVEMENT DISORDERS, 2024, 39 : S105 - S106
  • [29] Trk receptor alterations in Alzheimer's disease
    Connor, B
    Young, D
    Lawlor, P
    Gai, W
    Waldvogel, H
    Faull, RLM
    Dragunow, M
    MOLECULAR BRAIN RESEARCH, 1996, 42 (01): : 1 - 17
  • [30] Peroxynitrite-induced alterations in synaptosomal membrane proteins: Insight into oxidative stress in Alzheimer's disease
    Koppal, T
    Drake, J
    Yatin, S
    Jordan, B
    Varadarajan, S
    Bettenhausen, L
    Butterfield, DA
    JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) : 310 - 317